Prostate Tumor Volume & Density
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۲۰ • واحد: cm
حداقل ۱ — حداکثر ۲۰ • واحد: cm
حداقل ۱ — حداکثر ۲۰ • واحد: cm
حداقل ۰.۱ — حداکثر ۱۰۰۰ • واحد: ng/mL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- ——
- ——
The Prostate Tumor Volume & Density calculator is designed for bedside calculating prostate volume using ellipsoid formula and PSA density to help distinguish between benign prostatic hyperplasia (BPH) and prostate cancer in clinical practice. The resulting score directly guides clinician decision-making regarding adjusting systemic antineoplastic.
Clinical Guidelines & Evidence
Calculates prostate volume using ellipsoid formula and PSA density to help distinguish between benign prostatic hyperplasia (BPH) and prostate cancer. This tool assists in biopsy decision-making, risk stratification, and treatment planning for patients with elevated PSA levels.
Clinical Indication
The Prostate Tumor Volume & Density is indicated for bedside clinical practice to support Calculates prostate volume using ellipsoid formula and PSA density to help distinguish between benign prostatic hyperplasia (BPH) and prostate cancer. This tool assists in biopsy decision-making, risk stratification, and treatment planning for patients with elevated PSA levels.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival. Guideline pearl: May help guide active surveillance vs. treatment decisions.
Prostate Volume (mL) = Length × Width × Height × π/6; PSA Density (ng/mL²) = PSA (ng/mL) ÷ Prostate Volume (mL)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| prostate_length | float | Yes | Maximum anteroposterior (AP) diameter of prostate in cm(cm) |
| prostate_width | float | Yes | Maximum transverse (left-right) diameter of prostate in cm(cm) |
| prostate_height | float | Yes | Maximum craniocaudal (superior-inferior) diameter of prostate in cm(cm) |
| psa_value | float | Yes | Serum prostate-specific antigen (PSA) level in ng/mL(ng/mL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | — | — |
| — | — | — |
Evidence-Based References (EBM)
- Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145(5):984-7. doi: 10.1016/s0022-5347(17)38491-9.DOI: 10.1016/s0022-5347(17)38491-9
- Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 1992;147(3 Pt 2):817-21. doi: 10.1016/s0022-5347(17)37394-9.DOI: 10.1016/s0022-5347(17)37394-9
- Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSATZ) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology. 1994;43(5):601-6. doi: 10.1016/0090-4295(94)90170-8.DOI: 10.1016/0090-4295(94)90170-8
- Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst. 2013;105(14):1050-8. doi: 10.1093/jnci/djt151.DOI: 10.1093/jnci/djt151